REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,760 | -13.5% | 2,616 | +17.4% | 0.00% | -33.3% |
| Q2 2023 | $51,757 | +15.9% | 2,229 | -11.8% | 0.00% | +50.0% |
| Q1 2023 | $44,644 | -33.1% | 2,528 | +3.1% | 0.00% | -33.3% |
| Q4 2022 | $66,694 | +57.5% | 2,452 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $42,346 | +39.4% | 2,452 | +41.1% | 0.00% | +100.0% |
| Q2 2022 | $30,380 | +2.9% | 1,738 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,511 | -84.6% | 1,738 | -75.5% | 0.00% | -66.7% |
| Q4 2021 | $191,922 | -8.6% | 7,082 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $209,910 | -22.9% | 7,082 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $272,090 | +32.6% | 7,082 | +5.3% | 0.00% | +33.3% |
| Q1 2021 | $205,180 | -20.0% | 6,725 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $256,559 | +65.7% | 6,725 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $154,810 | -2.0% | 6,725 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $158,021 | – | 6,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |